Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study

Table 1 Demographics and clinical characteristics of the patients at baseline (n = 114), n (%)

Characteristics
Gender
Male	62 (54.39)
Female	52 (45.61)
Age (years)
≥ 65	9 (7.89)
≤ 65	105 (92.11)
Body mass index (kg/m2) (mean ± SD)	22.96 ± 3.37
Asian race	114 (100)
Dialysis history
< 1 year	38 (33.33)
≥ 1 year and < 3 years	39 (34.21)
≥ 3 years	37 (32.46)
Presence of complication
Hypertension	94 (82.46)
Diabetes mellitus	36 (31.57)
Anemia	1 (0.88)
Coronary artery disease	3 (2.63)
Hyperthyroidism	1 (0.88)
Thyroid	1 (0.88)